Non-animal testing methods could save drugmakers time and money, officials say ...

Patients with obesity sometimes have leptin resistance, and the "full" feeling does not get through to the brain. The new ...

The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop ...

Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster.

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...

Strengthening collaboration to drive innovation across AI, biomedical research, and translational medicine PUNE, ...

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

Targeted modulation of certain intracellular signaling proteins could represent an exciting new approach to drug development.

The FDA has proposed new rules to speed up the development of biosimilar drugs, aiming to reduce the costs of biologic ...

Balasegaram is executive director of the Global Antibiotic Research & Development Partnership. No matter how carefully we use the antibiotics we have, drug resistant infections will continue to gain ...

As Congress debates renewing the Act for ALS, it must prepare for the coming era of precision ALS medicine by prioritizing ...